Effect of Preoperative Diclofenac Potassium on Articaine Buccal Infitration Success

• Status: Completed
• Trial end date: 2018-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the effect of preoperative Diclofenac Potassium (50 mg Cataflam) on the anesthetic success of buccal infiltration with 4% articaine with epinephrine 1:200,000 in mandibular molars with symptomatic irreversible pulpitis.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Carticaine; Diclofenac

Criteria

Inclusion Criteria:

• Patients with active pain (moderate-to-severe) in mandibular molars.

• Patients with prolonged response to cold testing and electric pulp tester.

• Patient with the ability to understand and use pain scales.

• Patient with vital coronal pulp tissue on access.

• Patient who accept to enroll to the study.

Exclusion Criteria:

• Patients' allergies or any other contraindication to diclofenac potassium or articaine.

• Pregnant and lactating females.

• Patients having pain medication in the last 6 hours.

• Patient has more than one symptomatic mandibular tooth in the same quadrant.

• Patients with periradicular pathosis and/or radiolucency other than widened periodontal ligaments.

• Patients with active peptic ulcer and gastrointestinal disorders.

• Patients with history of bleeding problems or anticoagulant use within the last month.